TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20223599

Group type: EXPERIMENTAL
Intervention: High-dose corticosteroid therapy (methylprednisolone)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Alternative therapy (mitoxantrone)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Major depression (MD) receiving antidepressants
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 36
Study: 17668416

Group type: EXPERIMENTAL
Intervention: 6-hydroxybuspirone racemate (BMS-528215)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 6-hydroxybuspirone S-enantiomer (BMS-442606)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 6-hydroxybuspirone R-enantiomer (BMS-442608)
Number of subjects: 20

Group type: COMPARATOR
Intervention: buspirone
Number of subjects: 20
Study: 15878492

Group type: EXPERIMENTAL
Intervention: Inhalation of thermal water (active group, n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Normal saline (control group, n=19)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Inhalation of thermal water (active group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 39
Study: 12025921

Group type: EXPERIMENTAL
Intervention: Electrostimulation of the gastrocnemius muscle of the remaining leg, 2 hours per day for 8 weeks.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard exercise program for patients with limb amputation (Control group).
Number of subjects: 50
Study: 10465168

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (1 g daily, n=2836)
Number of subjects: 11324

Group type: EXPERIMENTAL
Intervention: Combined treatment (n-3 PUFA and vitamin E, n=2830)
Number of subjects: 11324

Group type: EXPERIMENTAL
Intervention: Vitamin E (300 mg daily, n=2830)
Number of subjects: 11324

Group type: COMPARATOR
Intervention: Control group (none, n=2828)
Number of subjects: 11324
Study: 7797378

Group type: EXPERIMENTAL
Intervention: Crude antigens from Trichinella spiralis in ELISA
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Western blot analysis for T. spiralis
Number of subjects: 3
Study: 30527287

Group type: EXPERIMENTAL
Intervention: Polyherbal combination tablets
Number of subjects: 30

Group type: COMPARATOR
Intervention: Turmeric tablets
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 28096034

Group type: EXPERIMENTAL
Intervention: Self-referral to inpatient treatment (SRIT) contract
Number of subjects: 53
Study: 26742418

Group type: EXPERIMENTAL
Intervention: McGRATH® MAC (MAC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Macintosh Laryngoscope (McL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Airwayscope® (AWS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MAC and AWS groups
Number of subjects: 60
Study: 23135962

Group type: EXPERIMENTAL
Intervention: IL6 -174CC genotype in AMI group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: CD14 -260TT genotype in AMI group
Number of subjects: 102

Group type: COMPARATOR
Intervention: CD14 and IL6 variants
Number of subjects: 102
Study: 22030384

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5mg daily
Number of subjects: 3148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3148
Study: 19885409

Group type: EXPERIMENTAL
Intervention: Fluoride treatment (FTB)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Titanium dioxide grit-blasted (TB) implants
Number of subjects: 27
Study: 17316373

Group type: EXPERIMENTAL
Intervention: Strength training (n=11)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Endurance training (n=12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Strength or endurance training
Number of subjects: 23
Study: 15643795

Group type: EXPERIMENTAL
Intervention: New model of antenatal care with fewer visits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard antenatal care model
Number of subjects: 0
Study: 11350556

Group type: EXPERIMENTAL
Intervention: Epinephrine irrigation (40‐120 mL of 1:1,000,000 epinephrine)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (no epinephrine irrigation)
Number of subjects: 173
Study: 9390594

Group type: EXPERIMENTAL
Intervention: Cisatracurium 5, 10, or 15 microg/kg
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Vecuronium 100 microg/kg
Number of subjects: 165

Group type: COMPARATOR
Intervention: Neostigmine 5, 10, 30, or 50 microg/kg
Number of subjects: 165
Study: 8193488

Group type: EXPERIMENTAL
Intervention: High-dose bovine surfactant (100 mg/kg birth weight)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low-dose bovine surfactant (50 mg/kg birth weight)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 3300375

Group type: EXPERIMENTAL
Intervention: Bromocriptine, 2.5 mg twice daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31306084

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 with dihydroartemisinin-piperaquine plus a single low dose primaquine
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 without antimalarial drugs
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 with and without antimalarial drugs
Number of subjects: 193
Study: 29460071

Group type: EXPERIMENTAL
Intervention: 3D roadmap
Number of subjects: 30

Group type: COMPARATOR
Intervention: CO2 wedged hepatic vein portography
Number of subjects: 30
Study: 27412317

Group type: EXPERIMENTAL
Intervention: High saturated fatty acid (SFA) diet
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High polyunsaturated fatty acid (PUFA) diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Low fatty acid diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 37
Study: 25327812

Group type: EXPERIMENTAL
Intervention: Nemonoxacin (500 mg) + Antacid (318 mg Al(3+) and 496 mg Mg(2+))
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nemonoxacin (500 mg) + Antacid (4 hours after)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nemonoxacin (500 mg) + Antacid (2 hours before)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nemonoxacin (500 mg) + Ferrous sulfate (60 mg Fe(2+))
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nemonoxacin (500 mg) + Calcium carbonate (600 mg Ca(2+))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nemonoxacin (500 mg) alone
Number of subjects: 24
Study: 22521072

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 755

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 755
Study: 20737683

Group type: EXPERIMENTAL
Intervention: INFLUVIR vaccine administered intranasally
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PANDEFLU vaccine administered intramuscularly
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 30
Study: 19923507

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 9
Study: 16168872

Group type: EXPERIMENTAL
Intervention: Cigarette smoking prevalence among men
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Cigarette smoking prevalence among women
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Age of smoking initiation
Number of subjects: 1021
Study: 12875144

Group type: EXPERIMENTAL
Intervention: Exercise-with-adherence intervention (individualized graphic feedback on exercise goals and participation, problem-solving support by nurses)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Exercise-only group
Number of subjects: 16
Study: 10714789

Group type: EXPERIMENTAL
Intervention: Newer antibiotics (macrolides and quinolones)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional antimicrobial therapy (beta-lactam therapy)
Number of subjects: 0
Study: 8684787

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 1831006

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg/day
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg/day
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin 80 mg/day
Number of subjects: 8245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin (20-40 mg/day)
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg/day)
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin (80 mg/day)
Number of subjects: 8245
Study: 6861303

Group type: EXPERIMENTAL
Intervention: Exercise group (daily prescribed physical exercise for 60 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (resumed customary activities)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 12
Study: 31155473

Group type: EXPERIMENTAL
Intervention: Calorie tracking app
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Wearable Bite Counter device
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Kcal tracking app
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Photo meal app
Number of subjects: 124
Study: 29746823

Group type: EXPERIMENTAL
Intervention: Behavior-change intervention (weekly 30-minute telephone sessions for 12 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Attention control (CTL; health status monitoring sessions)
Number of subjects: 38
Study: 26733186

Group type: EXPERIMENTAL
Intervention: ToyBox-intervention (24-week duration)
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: ToyBox-intervention
Number of subjects: 859

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 859
Study: 24671907

Group type: EXPERIMENTAL
Intervention: THC/CBD (Sativex®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22657586

Group type: EXPERIMENTAL
Intervention: Standardized DRI-covering low-calorie formula diet over three months (n=32)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Baseline micronutrient intake (dietary record collection)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 104
Study: 20674983

Group type: EXPERIMENTAL
Intervention: Venlafaxine treatment
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (106 individuals)
Number of subjects: 117
Study: 17180128

Group type: EXPERIMENTAL
Intervention: Test solution (sterile, isotonic solution patterned after human amniotic fluid), 2.5 ml/kg every 3 hours via OG/NG tube for up to 7 days.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham administration (control), every 3 hours via OG/NG tube for up to 7 days.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Test solution (compared to sham),
Number of subjects: 20
Study: 15677431

Group type: EXPERIMENTAL
Intervention: Switching to olanzapine (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prolactin-elevating antipsychotics (control)
Number of subjects: 0
Study: 11384820

Group type: EXPERIMENTAL
Intervention: individualized, comprehensive, home‐based cardiac rehabilitation
Number of subjects: 99
Study: 9566570

Group type: EXPERIMENTAL
Intervention: N2O pneumoperitoneum
Number of subjects: 40

Group type: COMPARATOR
Intervention: CO2 pneumoperitoneum
Number of subjects: 40
Study: 7816967

Group type: EXPERIMENTAL
Intervention: Ts group (coal workers with pneumoconiosis)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tn group (coal workers with normal pulmonary X‐rays)
Number of subjects: 80

Group type: COMPARATOR
Intervention: HTn group (underground miners with normal pulmonary X‐rays)
Number of subjects: 80
Study: 2973694

Group type: EXPERIMENTAL
Intervention: Yeast-derived recombinant hepatitis B vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma-derived hepatitis B vaccine
Number of subjects: 0
Study: 29661486

Group type: EXPERIMENTAL
Intervention: Socially evaluated cold pressure test
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 80
Study: 28554451

Group type: EXPERIMENTAL
Intervention: Removable bite-blocks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 21
Study: 25042995

Group type: EXPERIMENTAL
Intervention: Glipizide plus Aralia root bark extract (ARBE)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Glipizide alone
Number of subjects: 148
Study: 25230741

Group type: EXPERIMENTAL
Intervention: Catechin-rich green tea (615 mg/350 ml)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (92 mg/350 ml)
Number of subjects: 22
Study: 21136039

Group type: EXPERIMENTAL
Intervention: NIPSV
Number of subjects: 200

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 200
Study: 19524409

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (CRT)
Number of subjects: 85
Study: 17179244

Group type: EXPERIMENTAL
Intervention: ECG guidance for CVC placement
Number of subjects: 290

Group type: COMPARATOR
Intervention: NO-ECG guidance for CVC placement
Number of subjects: 290
Study: 15008650

Group type: EXPERIMENTAL
Intervention: Extraversion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activated positive affect items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral conditions
Number of subjects: 0
Study: 11703992

Group type: EXPERIMENTAL
Intervention: Azimilide 100 mg/day
Number of subjects: 1380

Group type: EXPERIMENTAL
Intervention: Azimilide 125 mg/day
Number of subjects: 1380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1380

Group type: EXPERIMENTAL
Intervention: Azimilide (100 and 125 mg/day)
Number of subjects: 1380
Study: 9627377

Group type: EXPERIMENTAL
Intervention: Tall oil phytosterols (21.2 mg/kg body weight/d)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Tall oil phytosterols
Number of subjects: 22
Study: 7706079

Group type: EXPERIMENTAL
Intervention: Relaxation hypnosis
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Long-term effects of autogenic training
Number of subjects: 12
Study: 2778240

Group type: EXPERIMENTAL
Intervention: Oral prednisone (20 mg three times daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 366807

Group type: EXPERIMENTAL
Intervention: Faustan (diazepam)
Number of subjects: 340
Study: 31871515

Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous Electric Nerve Stimulation) for 20 minutes, frequency adjusted for VAS 1-5 (subgroup 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous Electric Nerve Stimulation) for 20 minutes, frequency adjusted for VAS 6-10 (subgroup 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MENS (Microcurrent Nerve Stimulation) for 20 minutes, frequency adjusted for VAS 1-5 (subgroup 3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MENS (Microcurrent Nerve Stimulation) for 20 minutes, frequency adjusted for VAS 6-10 (subgroup 4)
Number of subjects: 60
Study: 28251153

Group type: EXPERIMENTAL
Intervention: Parotid salivary glucose measurement in type 2DM patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Blood glucose measurement in type 2DM patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mixed salivary glucose measurement in type 2DM patients
Number of subjects: 30
Study: 25703478

Group type: EXPERIMENTAL
Intervention: Conventional pattern 30 ms
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Conventional pattern 100 ms
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Navigated pattern 30 ms
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Navigated pattern 100 ms
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Short pulse groups (30 ms)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Long pulse groups (100 ms)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Navigated 100 ms
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional single-spot 100 ms
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Navigated 30 ms
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional 30 ms
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 30 ms groups
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 100 ms groups
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both 30 ms groups
Number of subjects: 74
Study: 25039412

Group type: EXPERIMENTAL
Intervention: Transnasal endoscopy (TNE)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard oesophago-gastro-duodenoscopy (SOGD)
Number of subjects: 157
Study: 21963936

Group type: EXPERIMENTAL
Intervention: HIV-1 gp120/NefTat vaccine with AS02A adjuvant
Number of subjects: 20

Group type: COMPARATOR
Intervention: Adjuvant alone or placebo
Number of subjects: 20
Study: 19948275

Group type: EXPERIMENTAL
Intervention: Verteporfin photodynamic therapy (VPDT)
Number of subjects: 4043
Study: 17519010

Group type: EXPERIMENTAL
Intervention: AQ+SP
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: AQ+AS
Number of subjects: 287

Group type: COMPARATOR
Intervention: CQ
Number of subjects: 287
Study: 15907056

Group type: EXPERIMENTAL
Intervention: 0.5% centbucridine in saline
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 1% centbucridine in saline
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 4% lignocaine in distilled water
Number of subjects: 99

Group type: COMPARATOR
Intervention: Unanaesthetized control (one eye)
Number of subjects: 99
Study: 11238754

Group type: EXPERIMENTAL
Intervention: 750 mL red wine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 g fried onions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 375 mL black tea
Number of subjects: 12
Study: 9540173

Group type: EXPERIMENTAL
Intervention: Pamidronate 45 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pamidronate 60 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg
Number of subjects: 70
Study: 8007079

Group type: EXPERIMENTAL
Intervention: Hypnosis with suggestions to enhance the DTH response to VZ antigen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hypnosis with suggestions to suppress the DTH response
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hypnosis with suggestions for relaxation only
Number of subjects: 24

Group type: COMPARATOR
Intervention: Skin testing without hypnosis
Number of subjects: 24
Study: 2179802

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse (0.12% chlorhexidine digluconate, 15 ml, three times a day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Chlorhexidine mouthrinse
Number of subjects: 70
Study: 408116

Group type: EXPERIMENTAL
Intervention: Single dose of 100 mg iron as ferrous glycocoll sulphate in micropellets
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Single dose of 50 mg iron as ferrous glycocoll sulphate in micropellets
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Iron preparation given at the end of breakfast
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Fasting absorption measurement
Number of subjects: 105
Study: 31580506

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) for 12 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control Group (CG) with standard physical activity recommendations
Number of subjects: 69
Study: 31433483

Group type: EXPERIMENTAL
Intervention: Housing First (HF) with Intensive Case Management (ICM)
Number of subjects: 1198

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 1198
Study: 28073036

Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate solution 800mL the night before and 400mL 2h prior to operation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fasting for 8h prior to operation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate solution
Number of subjects: 43
Study: 25957793

Group type: EXPERIMENTAL
Intervention: Daily lipid-based nutrient supplement
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Multiple micronutrients
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Iron and folic acid
Number of subjects: 1009
Study: 23241869

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic appendectomy (SPLA)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Conventional laparoscopic appendectomy (CLA)
Number of subjects: 224
Study: 21801246

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri supplementation during the last month of gestation and through the first year of life
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Presence of L. reuteri in stool in the first week of life
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: High Th2/Th1 ratio (CCL22/CXCL10) at birth
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: High Th1-associated chemokine levels
Number of subjects: 161
Study: 19001543

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 16732009

Group type: EXPERIMENTAL
Intervention: Inhaled human insulin (Exubera)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 427
Study: 16736343

Group type: EXPERIMENTAL
Intervention: Preoperative ultrasonographic mapping (PUSM)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Physical examination (PE)
Number of subjects: 70
Study: 14753759

Group type: EXPERIMENTAL
Intervention: Self-assessment manual for quality dental practice with feedback on scores and references
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-assessment manual for quality dental practice with attendance at a continuing education course on Quality Improvement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-assessment manual for quality dental practice only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-assessment manual for quality dental practice only at 1 year
Number of subjects: 0
Study: 10589362

Group type: EXPERIMENTAL
Intervention: Infliximab in combination with methotrexate (MTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Infliximab alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infliximab with high-dose MTX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0